||Vlado STANKOVSKI // 1.06 Objavljeno vabljeno predavanje na znanstveni konferenci
||STANKOVSKI, Vlado. The use of artificial
intelligence in interpretation of clinical trials. V: ANTYPAS, George (ur.).
2nd Balkan congress of oncology, Izmir, Turkey, September 10-14, 1998.
Bologna: Monduzzi editore, 1999, str. 51-56.
||The aim of clinical trials
is to produce scientifically valid results thus, helping doctors understand a
treatment's benefits and drawbacks. They can be used not only to understand new
treatments, but also to determine new ways of using existing treatments.
Currently, only statistical methods are being used in the process of
understanding clinical trials and other medical problems in general. The purpose
of this paper is to show how state-of the-art methods of artificial intelligence
and machine learning in particular, can also be used for data analysis and
interpretation. The later approach can be especially suitable in the case of
clinical trials. This new methodology is a qualitative extension of the
methodology that uses only statistical methods and its use is therefore,
recommended in any clinical study. In this lecture, the artificial intelligence
approach is worked through an example. [COBISS.SI-ID 10749913]
||1.06 Objavljeno vabljeno predavanje na znanstveni konferenci
||10749913 Polni zapis iz sistema COBISS
Vpisal 2009/06/10 11:56